ISRCTN38393880已完成2 期
Add-on treatment with Cerebrolysin improves clinical symptoms in amyotrophic lateral sclerosis patients: results of a prospective, single-center, placebo-controlled, randomized, double-blind, Phase II study
Instituto Cardiológico Banfield0 个研究点目标入组 20 人开始时间: 2024年1月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Either sex and at least 18 years of age
- •2. Clinically definite diagnosis of ALS according to the El Escorial and revised Airlie House diagnostic criteria
- •3. Limb onset and/or bulbar onset with pyramidal signs
- •4. Modified Ashworth Spasticity Scale score of 3
- •5. Informed consent
排除标准
- •1. Co-morbidities such as hepatic disease, renal failure or severe renal impairment, coronary disease, epilepsy, Parkinson’s disease, or dementia
- •2. Any condition that might interfere with compliance with study procedures or influence outcome assessment
- •3. Pregnant or breastfeeding
- •4. Participation in another interventional study within the previous 2 months
- •5. Contraindication to Cerebrolysin
- •6. Concomitant use of ginkgo biloba, erythropoietin, citicoline, and amantadine
研究者
相似试验
已完成
不适用
Evaluation of efficacy and safety of Cerebrolysin as add-on therapy in patients with acute stroke after failed recanalisation therapyAcute ischemic strokeCirculatory SystemStroke, not specified as haemorrhage or infarctionISRCTN15233803niversity Hospital Centre Zagreb46
招募中
3 期
Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke.Stroke, IschemicStroke, AcuteStroke SequelaeNCT04904341Military Institute od Medicine National Research Institute50
进行中（未招募）
4 期
sing a neuroprotective drug to treat patients who have a serious type of brain bleeding caused by a rupture of a weakened blood vessel (aneurysm)ISRCTN16818128niversity Hospital Centre Zagreb50
已完成
3 期
The efficacy of Cerebrolysin in the treatment of acute ischemic strokeCerebral infarctionCerebral infarction.IRCT138803272042N1Research Deputy, Shahid Beheshti University of Medical Sciences100
终止
4 期
The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and NeurorecoveryTraumatic Brain InjuryNCT01606111Ever Neuro Pharma GmbH46